Claudin association with CD81 defines hepatitis C virus entry. 2010

Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
Institute for Biomedical Research, University of Birmingham, Birmingham B15 2TT, United Kingdom.

Viruses initiate infection by attaching to molecules or receptors at the cell surface. Hepatitis C virus (HCV) enters cells via a multistep process involving tetraspanin CD81, scavenger receptor class B member I, and the tight junction proteins Claudin-1 and Occludin. CD81 and scavenger receptor class B member I interact with HCV-encoded glycoproteins, suggesting an initial role in mediating virus attachment. In contrast, there are minimal data supporting Claudin-1 association with HCV particles, raising questions as to its role in the virus internalization process. In the present study we demonstrate a relationship between receptor active Claudins and their association and organization with CD81 at the plasma membrane by fluorescence resonance energy transfer and stoichiometric imaging methodologies. Mutation of residues 32 and 48 in the Claudin-1 first extracellular loop ablates CD81 association and HCV receptor activity. Furthermore, mutation of the same residues in the receptor-inactive Claudin-7 molecule enabled CD81 complex formation and virus entry, demonstrating an essential role for Claudin-CD81 complexes in HCV infection. Importantly, Claudin-1 associated with CD81 at the basolateral membrane of polarized HepG2 cells, whereas tight junction-associated pools of Claudin-1 demonstrated a minimal association with CD81. In summary, we demonstrate an essential role for Claudin-CD81 complexes in HCV infection and their localization at the basolateral surface of polarized hepatoma cells, consistent with virus entry into the liver via the sinusoidal blood and association with basal expressed forms of the receptors.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
April 2011, Biochemical Society transactions,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
May 2004, Proceedings of the National Academy of Sciences of the United States of America,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
March 1999, Hepatology (Baltimore, Md.),
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
April 2011, Biochemical Society transactions,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
April 2008, PloS one,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
May 2009, BMC microbiology,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
February 2019, Journal of viral hepatitis,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
May 2016, The Journal of general virology,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
July 2013, Cellular microbiology,
Helen J Harris, and Christopher Davis, and Jonathan G L Mullins, and Ke Hu, and Margaret Goodall, and Michelle J Farquhar, and Christopher J Mee, and Kitty McCaffrey, and Stephen Young, and Heidi Drummer, and Peter Balfe, and Jane A McKeating
December 2020, The Journal of biological chemistry,
Copied contents to your clipboard!